Societe D'Exploitation Du Centre Cardiologique Du Nord

The Departement de Cardiologie is running studies across the full spectrum of cardiovascular diseases, with a strong focus on improving treatment choices for heart failure, atrial fibrillation, and structural heart conditions.

• Testing new approaches to maintain heart rhythm and reduce recurrent atrial fibrillation in patients with preserved heart function
• Evaluating strategies to prevent stroke and systemic embolism in people with atrial fibrillation
• Assessing whether treatment changes can safely support recovery in heart failure patients

These trials aim to refine everyday cardiac care by comparing newer therapies with standard treatment, with the goal of improving safety, symptom control, and long-term outcomes.

Several trials at this site focus on atrial fibrillation, a common rhythm disorder linked to stroke risk and other cardiovascular complications.

• Studying better ways to prevent stroke and systemic embolism in patients with atrial fibrillation
• Exploring whether tailored antithrombotic care can improve protection while lowering bleeding risk after valve procedures
• Looking at rhythm-control support in people with hypertension and preserved left ventricular function

The research is designed to improve how clinicians balance clot prevention and bleeding risk, while also helping maintain stable heart rhythm in selected patient groups.

Research in heart failure is an important part of the portfolio at the Centre Cardiologique Du Nord, especially for patients whose heart function has improved after treatment.

• Examining whether stopping beta-blocker therapy is safe in patients with recovered left ventricular function
• Evaluating treatments that may help prevent worsening heart pumping ability after recovery
• Studying ways to reduce relapse and other adverse cardiovascular outcomes

These studies are intended to guide long-term management decisions and clarify which patients may benefit from continuing or adjusting heart failure therapy.

The site also investigates structural heart disease, including aortic valve stenosis and tricuspid regurgitation, with attention to patients undergoing advanced cardiac procedures.

• Assessing personalized antithrombotic care after transcatheter aortic valve implantation
• Studying support strategies around surgery for functional tricuspid regurgitation
• Focusing on reducing complications such as bleeding, low cardiac output, and thromboembolic events

These trials aim to improve procedural safety and help identify the most effective ways to support patients before and after valve intervention.

Another research theme involves coronary artery disease, particularly in patients with a chronically occluded coronary artery who undergo coronary angioplasty.

• Comparing shorter and longer antiplatelet treatment strategies after successful coronary intervention
• Measuring the impact on bleeding, ischemic events, and overall clinical safety
• Supporting more individualized treatment decisions after revascularization

The goal is to find a safer and more effective balance between preventing clot-related events and limiting treatment-related harm.

Clinical research at this hospital also includes acute myocarditis, an inflammatory condition that can affect heart muscle function and lead to significant complications.

• Evaluating treatments for patients with confirmed myocarditis and left ventricular dysfunction
• Studying whether early anti-inflammatory therapy can improve recovery of heart function
• Tracking major cardiovascular events and persistent impairment over time

This work is focused on improving diagnosis-linked treatment decisions and identifying therapies that may help preserve or restore cardiac performance.